{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:38:58Z","timestamp":1790732338362,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2017E4400100#"],"award-info":[{"award-number":["2017E4400100#"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ebiom.2018.08.029","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T18:22:32Z","timestamp":1534789352000},"page":"76-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Impact of host-pathogen-treatment tripartite components on early mortality of patients with Escherichia coli bloodstream infection: Prospective observational study"],"prefix":"10.1016","volume":"35","author":[{"given":"Eun-Jeong","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dokyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyukmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeong Seob","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hee","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Uh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ah.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Hwan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9290-897X","authenticated-orcid":false,"given":"Seok Hoon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ebiom.2018.08.029_bb0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/1469-0691.12144","article-title":"Incidence of bloodstream infection: a review of population-based studies","volume":"19","author":"Laupland","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.ebiom.2018.08.029_bb0010","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/AAC.05753-11","article-title":"Bacteremia caused by extended-spectrum-beta-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality","volume":"56","author":"Chung","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.ebiom.2018.08.029_bb0015","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1128\/AAC.00143-10","article-title":"Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy","volume":"54","author":"Tumbarello","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2018.08.029_bb0020","series-title":"Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-Central Line Associated Bloodstream Infection)","author":"CDC","year":"2018"},{"issue":"2","key":"10.1016\/j.ebiom.2018.08.029_bb0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1556\/EuJMI.3.2013.2.2","article-title":"Non-culture-based methods to diagnose bloodstream infection: does it work?","volume":"3","author":"Skvarc","year":"2013","journal-title":"Eur J Microbiol Immunol (Bp)"},{"issue":"4","key":"10.1016\/j.ebiom.2018.08.029_bb0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cmi.2015.01.003","article-title":"Blood culture-based diagnosis of bacteraemia: state of the art","volume":"21","author":"Opota","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.ebiom.2018.08.029_bb0035","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1086\/315418","article-title":"Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC","volume":"181","author":"Russo","year":"2000","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2018.08.029_bb0040","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1469-0691.2010.03262.x","article-title":"Trends among pathogens reported as causing bacteraemia in England, 2004-2008","volume":"17","author":"Wilson","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.ebiom.2018.08.029_bb0045","doi-asserted-by":"crossref","first-page":"E170","DOI":"10.1111\/j.1469-0691.2012.03845.x","article-title":"Population-based burden of bloodstream infections in Finland","volume":"18","author":"Skogberg","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.ebiom.2018.08.029_bb0050","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1128\/CMR.00125-13","article-title":"Escherichia coli ST131, an intriguing clonal group","volume":"27","author":"Nicolas-Chanoine","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.ebiom.2018.08.029_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cmi.2015.01.001","article-title":"Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England","volume":"21","author":"Abernethy","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.ebiom.2018.08.029_bb0060","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1469-0691.2011.03587.x","article-title":"Risk factors for recurrence and death after bacteraemia: a population-based study","volume":"17","author":"Jensen","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.ebiom.2018.08.029_bb0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/jhm.877","article-title":"The clinical impact of fluoroquinolone resistance in patients with E. coli bacteremia","volume":"6","author":"Camins","year":"2011","journal-title":"J Hosp Med"},{"issue":"2","key":"10.1016\/j.ebiom.2018.08.029_bb0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1086\/324742","article-title":"Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime","volume":"34","author":"Wong-Beringer","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2018.08.029_bb0075","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1128\/AAC.48.12.4574-4581.2004","article-title":"Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy","volume":"48","author":"Kang","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ebiom.2018.08.029_bb0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4161\/21505594.2014.991234","article-title":"Impact of virulence genes on sepsis severity and survival in Escherichia coli bacteremia","volume":"6","author":"Mora-Rillo","year":"2015","journal-title":"Virulence"},{"issue":"3","key":"10.1016\/j.ebiom.2018.08.029_bb0085","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1128\/JCM.01902-10","article-title":"Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia","volume":"49","author":"Lefort","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ebiom.2018.08.029_bb0090","article-title":"Kor-GLASS system","author":"Lee","year":"2018","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.ebiom.2018.08.029_bb0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2018.08.029_bb0100","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. On behalf of the working group on Sepsis-related problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.ebiom.2018.08.029_bb0105","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.ebiom.2018.08.029_bb0110","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1365-2958.2006.05172.x","article-title":"Sex and virulence in Escherichia coli: an evolutionary perspective","volume":"60","author":"Wirth","year":"2006","journal-title":"Mol Microbiol"},{"issue":"10","key":"10.1016\/j.ebiom.2018.08.029_bb0115","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/AEM.66.10.4555-4558.2000","article-title":"Rapid and simple determination of the Escherichia coli phylogenetic group","volume":"66","author":"Clermont","year":"2000","journal-title":"Appl Environ Microbiol"},{"issue":"6","key":"10.1016\/j.ebiom.2018.08.029_bb0120","doi-asserted-by":"crossref","first-page":"e00377","DOI":"10.1128\/mBio.00377-13","article-title":"The epidemic of extended-spectrum-beta-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx","volume":"4","author":"Price","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.ebiom.2018.08.029_bb0125","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement","author":"Clinical and Laboratory Standards Institute","year":"2015"},{"issue":"1","key":"10.1016\/j.ebiom.2018.08.029_bb0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","article-title":"Multiplex PCR for detection of acquired carbapenemase genes","volume":"70","author":"Poirel","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2018.08.029_bb0135","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1128\/JCM.02353-09","article-title":"Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli","volume":"48","author":"Rodriguez-Bano","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.ebiom.2018.08.029_bb0140","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1128\/AAC.01065-13","article-title":"The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics","volume":"57","author":"Banerjee","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ebiom.2018.08.029_bb0145","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1128\/AAC.00119-14","article-title":"Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a Canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage","volume":"58","author":"Peirano","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ebiom.2018.08.029_bb0150","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1099\/jmm.0.000224","article-title":"Molecular epidemiology of bloodstream associated E. coli ST131 H30-Rx subclone infection in a region with high quinolone resistance","volume":"65","author":"Can","year":"2016","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.ebiom.2018.08.029_bb0155","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","article-title":"Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome","volume":"49","author":"Kang","year":"2005","journal-title":"Antimicrob Agents Chemother"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418303190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418303190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:49:40Z","timestamp":1762454980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396418303190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":31,"alternative-id":["S2352396418303190"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.08.029","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of host-pathogen-treatment tripartite components on early mortality of patients with Escherichia coli bloodstream infection: Prospective observational study","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}